1


CanniMed Therapeutics

Leadership team
Brent Zettl (Founder)
Products/ Services
Biotechnology, Cannabis, Health Care, Manufacturing, Medical, Wellness
Number of Employees
0 - 50
Headquarters
Saskatoon, Saskatchewan, Canada
Established
2013
Traded as
TSX:CMED
Overview
Location
Summary
CanniMed Therapeutics Inc. is a Canadian-based, global leader in the production and sale of pharmaceutical-grade cannabis products and related services.
History
CanniMed Therapeutics Inc. was founded in 2013, producing and selling natural, plant-based medical cannabis products and services. Through its active involvement in clinical research and product development, CanniMed creates sustainable and responsible solutions in addressing the needs and demands of medical, retail, and recreational consumers.
Mission
To provide the world with the highest quality, pharmaceutical-grade cannabis-based products and services, enabling optimal health and wellness outcomes.
Vision
To lead the innovation and development of new and innovative cannabis-based products and services, to become a leading global provider of health and wellness solutions.
Key Team
Brent Zettl (Founder)
Recognition and Awards
CanniMed has received numerous awards, including being named Canada’s Top Cannabis Licensed Producer in 2018 by the Canadian Cannabis Awards, being named one of Canada’s Fastest-Growing Companies in 2019 by Canadian Business Magazine, and the 2019 Canadian Cannabis Award for Finest Canadian-Produced Organic Cannabis Flower. In 2020, CanniMed was named a 2020 Canadian Cannabis Industry Leader and was winner of the 2020 Canadian Cannabis Award for Quality, Potency and Purity
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Leadership team
Brent Zettl (Founder)
Products/ Services
Biotechnology, Cannabis, Health Care, Manufacturing, Medical, Wellness
Number of Employees
0 - 50
Headquarters
Saskatoon, Saskatchewan, Canada
Established
2013
Traded as
TSX:CMED
